Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
Phase 2
Active, not recruiting
- Conditions
- 16P11.2 Deletion Syndrome
- Interventions
- Drug: Placebo oral tablet
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Clinical Research Associates, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04271332
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸New York State Psychiatric Institute (NYSPI), New York, New York, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
News
No news found